← Leaderboards
Ken Carter
Biotherapeutics, Inc.
$148,288
Attributed
$148,288
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$148,288 · 1
By mechanism
R43$148,288 · 1
Top collaborators
No co-investigators on record.
Most similar at Biotherapeutics, Inc.
Same institution · by research overlap
- Raquel Hontecillas$3,315,956
- Andrew Leber$4,071,154
- Nuria Tubau Juni$2,445,560
Others in their field
Top investigators on “Absorption”
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$82,226,988
- George R Painter · Chimerix, Inc.$36,309,505
- Gregory H Reaman · National Childhood Cancer Foundation$31,993,642
- Mark Donowitz · Johns Hopkins University$26,452,142
- Ehud Isacoff · University Of California Berkeley$23,916,000
- Lihong Wang · Texas A&M University System$22,538,040
Research focus
AbsorptionAcyltransferaseAdverse EffectsAffinityAgonistAnalogAnti-Infective AgentsAnti-InflammatoryAnti-Inflammatory AgentsBaseBinding (Molecular Function)BiochemistryBiological Response Modifier TherapyBotanicalsCalorimetryCellsChronicClinical TrialsColitisCommercial ApplicationCommercializationCyclic AmpCyclic Amp-Dependent Protein KinasesAbscisic Acid